Halper Sadeh LLC、SLP、HUN、OLN、PULMの取引における株主の公正性を調査

Investigation into potential violations in Huntsman's sale to Olin may reduce deal value or impose additional costs.

Investigation into Olin's merger with Huntsman may lead to increased consideration or other relief, potentially diluting Olin shareholders.

Investigation into Pulmatrix's merger with Eos SENOLYTIX may seek increased consideration or additional disclosures, negatively impacting deal terms.

Investigation into Simulations Plus's sale to Altaris for $18.50 per share may seek higher price or additional relief, creating uncertainty.